TY - JOUR
T1 - Crystal structure of the cyclostreptin-tubulin adduct
T2 - Implications for tubulin activation by taxane-site ligands
AU - Balaguer, Francisco de Asís
AU - Mühlethaler, Tobias
AU - Estévez-Gallego, Juan
AU - Calvo, Enrique
AU - Giménez-Abián, Juan Francisco
AU - Risinger, April L.
AU - Sorensen, Erik J.
AU - Vanderwal, Christopher D.
AU - Altmann, Karl Heinz
AU - Mooberry, Susan L.
AU - Steinmetz, Michel O.
AU - Oliva, María Ángela
AU - Prota, Andrea E.
AU - Díaz, J. Fernando
N1 - Publisher Copyright:
© 2019 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2019/3/2
Y1 - 2019/3/2
N2 - It has been proposed that one of the mechanisms of taxane-site ligand-mediated tubulin activation is modulation of the structure of a switch element (the M-loop) from a disordered form in dimeric tubulin to a folded helical structure in microtubules. Here, we used covalent taxane-site ligands, including cyclostreptin, to gain further insight into this mechanism. The crystal structure of cyclostreptin-bound tubulin reveals covalent binding to βHis229, but no stabilization of the M-loop. The capacity of cyclostreptin to induce microtubule assembly compared to other covalent taxane-site agents demonstrates that the induction of tubulin assembly is not strictly dependent on M-loop stabilization. We further demonstrate that most covalent taxane-site ligands are able to partially overcome drug resistance mediated by βIII-tubulin (βIII) overexpression in HeLa cells, and compare their activities to pironetin, an interfacial covalent inhibitor of tubulin assembly that displays invariant growth inhibition in these cells. Our findings suggest a relationship between a diminished interaction of taxane-site ligands with βIII-tubulin and βIII tubulin-mediated drug resistance. This supports the idea that overexpression of βIII increases microtubule dynamicity by counteracting the enhanced microtubule stability promoted by covalent taxane-site binding ligands.
AB - It has been proposed that one of the mechanisms of taxane-site ligand-mediated tubulin activation is modulation of the structure of a switch element (the M-loop) from a disordered form in dimeric tubulin to a folded helical structure in microtubules. Here, we used covalent taxane-site ligands, including cyclostreptin, to gain further insight into this mechanism. The crystal structure of cyclostreptin-bound tubulin reveals covalent binding to βHis229, but no stabilization of the M-loop. The capacity of cyclostreptin to induce microtubule assembly compared to other covalent taxane-site agents demonstrates that the induction of tubulin assembly is not strictly dependent on M-loop stabilization. We further demonstrate that most covalent taxane-site ligands are able to partially overcome drug resistance mediated by βIII-tubulin (βIII) overexpression in HeLa cells, and compare their activities to pironetin, an interfacial covalent inhibitor of tubulin assembly that displays invariant growth inhibition in these cells. Our findings suggest a relationship between a diminished interaction of taxane-site ligands with βIII-tubulin and βIII tubulin-mediated drug resistance. This supports the idea that overexpression of βIII increases microtubule dynamicity by counteracting the enhanced microtubule stability promoted by covalent taxane-site binding ligands.
KW - Cyclostreptin
KW - Microtubules
KW - Multidrug resistance
KW - Taxanes
KW - Tubulin
UR - http://www.scopus.com/inward/record.url?scp=85063686237&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063686237&partnerID=8YFLogxK
U2 - 10.3390/ijms20061392
DO - 10.3390/ijms20061392
M3 - Article
C2 - 30897704
AN - SCOPUS:85063686237
SN - 1661-6596
VL - 20
JO - International journal of molecular sciences
JF - International journal of molecular sciences
IS - 6
M1 - 1392
ER -